logo
Select company
Select metric
-5888.75%EBIT Margin
VS
Market
2
Sector
8
Industry
15
History
20
$ 1.77Close
$ 1.15 - $ 5.82 52-Week Range
Ticker Information

Ticker

HUMA

Company Name

HUMACYTE INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

HUMACYTE INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

HUMA - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -48.17M-5888.75%$ 818K
3/31/2025$ -67.2M-12999.03%$ 517K
12/31/2024$ -139.42M0%$ 0
9/30/2024$ -144.37M0%$ 0
6/30/2024$ -132.14M0%$ 0
3/31/2024$ -98.99M0%$ 0
12/31/2023$ -104.18M0%$ 0
9/30/2023$ -82.88M0%$ 0
6/30/2023$ -81.99M-264474.19%$ 31K
3/31/2023$ -22.64M-1699.32%$ 1.33M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • HUMACYTE INC's latest trailing twelve months (TTM) EBIT % stands at 0%.
  • Over the past 5 years, HUMACYTE INC's average EBIT % has been -26636.37%.
  • The median EBIT % for HUMACYTE INC during this period was -1752.1%
  • HUMACYTE INC reached its highest EBIT % over the past 5 years at 2313.26%.
  • The lowest EBIT % recorded by HUMACYTE INC in the same timeframe -264474.19%

HUMACYTE INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
RNAC : CARTESIAN THERAPEUTICS INC -3506.14%MREO : MEREO BIOPHARMA GROUP PLC -10070%CRDF : CARDIFF ONCOLOGY INC -9344.14%NWBO : NORTHWEST BIOTHERAPEUTICS INC -6793.6%BTAI : BIOXCEL THERAPEUTICS INC -4022.24%ABEO : ABEONA THERAPEUTICS INC 19223.25%VTGN : VISTAGEN THERAPEUTICS INC -8633.59%INBX : INHIBRX BIOSCIENCES INC -11275.86%SEPN : SEPTERNA INC -12093.8%ICU : SEASTAR MEDICAL HOLDING CORP -1909.79%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for HUMACYTE INC is calculated as follows: EBIT [ $ -233.33K ] / Revenues [ $ 0 ]
(=) EBIT % [ 0% ]

HUMA - EBIT Margin, Last 5 years

-264474.19%

Minimum

Jun 30, 2023

2313.26%

Maximum

Sep 30, 2022

-26636.37%

Average

-1752.1%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.54% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.54%
median9.01%
std23.96%